Addressing BBB Heterogeneity: A New Paradigm for Drug Delivery to Brain Tumors
Effective treatments for brain tumors remain one of the most urgent and unmet needs in modern oncology. This is due not only to the presence of the neurovascular unit/blood–brain barrier (NVU/BBB) but also to the heterogeneity of barrier alteration in the case of brain tumors, which results in what...
Main Authors: | Jessica I. Griffith, Sneha Rathi, Wenqiu Zhang, Wenjuan Zhang, Lester R. Drewes, Jann N. Sarkaria, William F. Elmquist |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/12/1205 |
Similar Items
-
The Use of Tissue Engineering to Fabricate Perfusable 3D Brain Microvessels in vitro
by: Kalpani N. Udeni Galpayage Dona, et al.
Published: (2021-08-01) -
The neurovascular unit in diffuse intrinsic pontine gliomas
by: Fatma E. El-Khouly, et al.
Published: (2021-07-01) -
20-HETE Enzymes and Receptors in the Neurovascular Unit: Implications in Cerebrovascular Disease
by: Ezekiel Gonzalez-Fernandez, et al.
Published: (2020-09-01) -
Targeting Potassium Channels for Increasing Delivery of Imaging Agents and Therapeutics to Brain Tumors
by: Nagendra Sanyasihally Ningaraj, et al.
Published: (2013-05-01) -
Protection after stroke: cellular effectors of neurovascular unit integrity
by: Rafael Andres Posada-Duque, et al.
Published: (2014-08-01)